Brachytherapy Market Growth Accelerated by Technological Advancements
![]() |
Brachytherapy Market |
Brachytherapy is radiation
therapy used to treat various types of cancers including breast cancer,
cervical cancer, prostate cancer and other cancers. Brachytherapy involves
placing radioactive sources in, on or near the tumor site which provides
concentrated radiation to the tumor and spares surrounding healthy tissues from
radiation damage. It is a minimally invasive procedure with the advantage of
delivering higher doses of radiation directly to the cancer while sparing
nearby healthy tissues which results in fewer side effects compared to external
beam radiation therapy. The brachytherapy devices market includes equipment,
applicators and afterloaders devices. Advancements in brachytherapy such as
high dose rate brachytherapy, pulse dose rate brachytherapy and low dose rate
brachytherapy have enhanced treatment outcomes for various cancers.
The global brachytherapy market
is estimated to be valued at US$ 1119.99
Bn in 2023 and is expected to exhibit a CAGR of 19% over the forecast period 2024 to 2031, as highlighted
in a new report published by Coherent Market Insights.
Market Dynamics:
The increasing incidence of
various cancers is a major driverfueling the growth of the brachytherapy market.
According to WHO,cancer continues to be one of the leading causes of mortality
worldwide, accounting for nearly 10 million deaths in 2020. Brachytherapy has
emerged as a minimally invasive and effective cancer treatment option. Also the
increasing demand for brachytherapy as it provides localized, concentrated and
targeted radiation to cancerous tumors delivers higher radiation doses while
protecting healthy tissues from radiation damage compared to external beam
radiation therapy. Additionally, technological advancements in brachytherapy
such as advancement in applicators, imaging technologies, and devices are also
boosting the market growth. However, the stringent regulatory approval process
for brachytherapy devices may hinder market growth.
SWOT Analysis
Strength: Brachytherapy has
benefits over other cancer treatments such as external beam radiation therapy.
It allows for higher and more targeted doses of radiation to be delivered to
cancerous tumors. Brachytherapy also causes less harm to nearby healthy
tissues. Physicians can use catheters or applicators to precisely place
radioactive sources inside or next to tumors.
Weakness: Brachytherapy requires
extensive training and expertise to properly place radioactive sources within
or near tumors. If not performed correctly, it can result in excessive
radiation exposure to healthy tissues. Brachytherapy also necessitates close
monitoring and follow-up care post-procedure to check for complications.
Opportunity: With the aging
population and rising cancer incidence globally, the need for effective cancer
treatments will continues to grow in the coming years. Brachytherapy offers an
important treatment alternative especially for prostate, cervical, breast, and
other cancers. Technological advancements are also improving applicators and
delivery systems to optimize dose accuracy and patient comfort.
Threats: External beam radiation
therapy and newer modalities like proton therapy are becoming increasingly
advanced and competitive alternatives. Their non-invasive nature is appealing
to some patients. Stringent regulatory hurdles and product approvals also pose
challenges for brachytherapy system manufacturers.
Key Takeaways
The Global
Brachytherapy Market Size is expected to witness high growth over the
forecast period of 2024-2031 driven by increasing cancer cases, growing
popularity of minimally invasive procedures, and technological improvements.
The market size is projected to reach $1119.99
billion by 2031 at a CAGR of 19%.
Regional analysis shows North America currently dominates the
brachytherapy market due to advanced healthcare infrastructure, favorable
reimbursement landscape, and higher adoption rates. However, Asia Pacific is
expected grow the fastest during the forecast period, expanding at a CAGR of
over 21%, owing to rising medical tourism, economic growth, and investments in
cancer care facilities.
Key players operating in the brachytherapy market are Varian
Medical Systems, Elekta AB, Becton, Dickinson and Company, IsoRay, Inc., Eckert
& Ziegler BEBIG, and iCAD. Varian and Elekta hold leading global market
shares and continue to launch technologically advanced brachytherapy systems.
Smaller players are focusing on specialized treatments and applications
segments. Partnerships between device makers and cancer centers are also
increasing to support clinical research and training programs.
Get More Insights Here
https://www.newswirestats.com/brachytherapy-market-size-share-growth-outlook-2023/
Comments
Post a Comment